Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Cancers
Journal
Overview
Identity
Overview
Publication Venue For
Distinct Gene Expression Profiles of Matched Primary and Metastatic Triple-Negative Breast Cancers
. 14.
2022
Regulation of NKG2D Stress Ligands and Its Relevance in Cancer Progression
. 14.
2022
Pre-Clinical Study Evaluating Novel Protein Phosphatase 2A Activators as Therapeutics for Neuroblastoma
. 14.
2022
Modulation of the Tumor Microenvironment with Trastuzumab Enables Radiosensitization in HER2+ Breast Cancer
. 14.
2022
Repair-Assisted Damage Detection Reveals Biological Disparities in Prostate Cancer between African Americans and European Americans
. 14.
2022
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
. 14.
2022
Test/Retest Reliability and Validity of Remote vs. In-Person Anthropometric and Physical Performance Assessments in Cancer Survivors and Supportive Partners
. 14.
2022
Hpve6-usp46 mediated cdt2 stabilization reduces set8 mediated h4k20-methylation to induce gene expression changes
. 14.
2022
Higher radiation dose to the immune cells correlates with worse tumor control and overall survival in patients with stage iii nsclc: A secondary analysis of rtog0617
. 13.
2021
The brd9/7 inhibitor tp-472 blocks melanoma tumor growth by suppressing ecm-mediated oncogenic signaling and inducing apoptosis
. 13.
2021
Toll-like receptor-4 antagonist enhances the repair of ultraviolet radiation-induced DNA damage and augments anti-tumor immune responses in mice
. 13.
2021
Genomic landscape of angiosarcoma: A targeted and immunotherapy biomarker analysis
. 13.
2021
The effect of a histone deacetylase inhibitor (AR-42) and zoledronic acid on adult T-cell leukemia/lymphoma osteolytic bone tumors
. 13.
2021
Genomic characterization and therapeutic targeting of hpv undetected cervical carcinomas
. 13.
2021
Targeted liposomal chemotherapies to treat triple-negative breast cancer
. 13.
2021
Merkel cell carcinoma of the head and neck: Epidemiology, pathogenesis, current state of treatment and future directions
. 13.
2021
The bet inhibitor JQ1 augments the antitumor efficacy of gemcitabine in preclinical models of pancreatic cancer
. 13.
2021
Knocking out the vitamin d receptor enhances malignancy and decreases responsiveness to vitamin d3 hydroxyderivatives in human melanoma cells
. 13.
2021
Serine-threonine kinase receptor-associated protein (Strap) knockout decreases the malignant phenotype in neuroblastoma cell lines
. 13.
2021
Cathepsin k: A novel diagnostic and predictive biomarker for renal tumors
. 13.
2021
Diet-induced obesity impairs outcomes and induces multi-factorial deficiencies in effector t cell responses following anti-ctla-4 combinatorial immunotherapy in renal tumor-bearing mice
. 13.
2021
Positron emission tomography imaging of macrophages in cancer
. 13.
2021
Artificial tumor microenvironments in neuroblastoma
. 13.
2021
Assessing preclinical research models for immunotherapy for gynecologic malignancies
. 13.
2021
Identification of BXDC2 as a key downstream effector of the androgen receptor in modulating cisplatin sensitivity in bladder cancer
. 13:1-13.
2021
Integrin αvβ3 engagement regulates glucose metabolism and migration through focal adhesion kinase (Fak) and protein arginine methyltransferase 5 (prmt5) in glioblastoma cells
. 13:1-16.
2021
The effects of single nucleotide polymorphisms in cancer rnai therapies
. 12:1-20.
2020
Elavl1 role in cell fusion and tunneling membrane nanotube formations with implication to treat glioma heterogeneity
. 12:1-18.
2020
The antidiabetic agent acarbose improves anti-PD-1 and rapamycin efficacy in preclinical renal cancer
. 12:1-19.
2020
Actively targeted nanodelivery of echinomycin induces autophagy-mediated death in chemoresistant pancreatic cancer in vivo
. 12:1-17.
2020
MiR-216b/Smad3/BCL-2 axis is involved in smoking-mediated drug resistance in non-small cell lung cancer
. 12:1-16.
2020
Association of allostatic load with all-cause and cancer mortality by race and body mass index in the regards cohort
. 12:1-15.
2020
Identification of distinct heterogenic subtypes and molecular signatures associated with african ancestry in triple negative breast cancer using quantified genetic ancestry models in admixed race populations
. 12.
2020
Patient-derived xenograft models of pancreatic cancer: Overview and comparison with other types of models
. 12.
2020
Biological and clinical significance of the CCR5/CCL5 axis in hepatocellular carcinoma
. 12.
2020
PAICS, a purine nucleotide metabolic enzyme, is involved in tumor growth and the metastasis of colorectal cancer
. 12.
2020
Utilizing genome-wide mrna profiling to identify the cytotoxic chemotherapeutic mechanism of triazoloacridone C-1305 as direct microtubule stabilization
. 12.
2020
Inhibiting WNT ligand production for improved immune recognition in the Ovarian tumor microenvironment
. 12.
2020
An update on neurofibromatosis type 1-associated gliomas
. 12.
2020
Cachexia and sarcopenia in older adults with cancer: A comprehensive review
. 11.
2019
Immunotherapy in pediatric solid tumors—a systematic review
. 11.
2019
Immunohistochemical and Molecular Features of Melanomas Exhibiting Intratumor and Intertumor Histomorphologic Heterogeneity.
. 11.
2019
Prognostic role of androgen receptor in triple negative breast cancer: A multi-institutional study
. 11.
2019
A review of the role of wnt in cancer immunomodulation
. 11.
2019
Pulmonary carcinoid surface receptor modulation using histone deacetylase inhibitors
. 11.
2019
Genomic profiling of the steroidogenic acute regulatory protein in breast cancer: In silico assessments and a mechanistic perspective
. 11.
2019
Review: Targeting the transforming growth factor-beta pathway in ovarian cancer
. 11.
2019
Effects of SAHA and EGCG on growth potentiation of triple-negative breast cancer cells
. 11.
2019
Contemporary management of localized resectable pancreatic cancer
. 10.
2018
Regulation of EMT in colorectal cancer: A culprit in metastasis
. 9.
2017
The impact of DNA repair pathways in cancer biology and therapy
. 9.
2017
Cell proliferation in neuroblastoma
. 8.
2016
Cancer stem cells and their interaction with the tumor microenvironment in neuroblastoma
. 8:1-13.
2015
Aberrant GLI1 activation in DNA damage response, carcinogenesis and chemoresistance
. 7:2330-2352.
2015
The impact of hedgehog signaling pathway on DNA repair mechanisms in human cancer
. 7:1333-1348.
2015
PARP-1: Friend or foe of DNA damage and repair in tumorigenesis?
. 5:943-958.
2013
Advances in viral vector-based TRAIL gene therapy for cancer
. 3:603-620.
2011
Cancer stem cells and pediatric solid tumors
. 3:298-318.
2011
Treatment Resistance Mechanisms of Malignant Glioma Tumor Stem Cells
. 3:621-635.
2011
Identity
International Standard Serial Number (issn)
2072-6694
Electronic International Standard Serial Number (eissn)
2072-6694